Granules India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0550 Name of the Signatory :- CHAITANYA TUMMALADesignation :- Company Secretary and Compliance Officer

Intimation of Schedule of Earnings Conference call for Q1, FY 2020-21

GRANULES INDIA LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2020 ,inter alia, to consider and approve Intimation of Board Meeting

Allotment of 1,50,000 equity shares under ESOS 2009

Granules Pharmaceuticals, Inc. issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for IDBI Trusteeship Services Ltd

Release of Pledge on the company''s shares

Completion of extinguishment of 71,01,374 Equity Shares of Granules India Limited ('Company') under the Buyback Offer

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 30, 2020 for Krishna Prasad Chigurupati